Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant
Business Wire India CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron variant (B.1.1.529) based on structural analysis…